🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT04483804
Recruiting Observational

Application of Radiomics in Breast Cancer

NCT04483804 · tracked via the Priya Life Science China tracker
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase
Observational
Started
2018-01-01
Last updated
2023-03-10

Condition(s) studied

Breast CancerUltrasoundElastographyPathologyRadiomics

Investigational drug(s) / intervention(s)

Endocrine therapy

Endocrine therapy: Endocrine therapy

Study summary

Little is known about the correlation between ultrasound characteristics (conventional, elastography and contrast enhanced ultrasound (CEUS) )and pathological prognostic factors in breast cancer. The aim of this study was to explore the correlation between ultrasound characteristics and pathological prognostic factors using radiomics.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: Clinical diagnosis of breast cancer Exclusion Criteria: Missing pathology Missing follow-up results Missing data

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
the Second Affiliated Hospital Zhejiang University School of Medicine Hanzhou Zhejiang Recruiting

More Second Affiliated Hospital, Zhejiang University, School of Medicine trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04483804 on ClinicalTrials.gov ↗ ← All trials in China